Sara Llufriu
Research group
- Advanced imaging in neuroimmunological diseases (ImaginEM) Junior group leader (R3B)
About me
Dra. Llufriu is a neurologist at the Neuroimmunology Unit of the Hospital Clínic de Barcelona. She coordinates the group of Advanced Imaging in Neuroimmunological Diseases (ImaginEM) of the Barcelona-IDIBAPS Clinical Research Foundation. Her projects involve technological development and clinical research, and for this she has received continuous public funding. She has published more than 100 scientific articles. She has also participated as a speaker in national and international courses and directed doctoral theses. Her group is part of international networks of researchers. She is currently secretary of the group of demyelinating diseases of the Catalan Society of Neurology.
Featured publications
-
Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis
Authors:Reference: Neurologia 2023. -
Diffusion tensor imaging metrics associated with future disability in multiple sclerosis
Authors:Reference: Scientific Reports 2023. -
Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease
Authors:Reference: Neurology 2022. -
Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
Authors:Reference: Lancet Neurology 2022. -
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
Authors:Reference: J Pers Med 2021. -
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability
Authors:Reference: Multiple Sclerosis Journal 2021. -
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Authors:Reference: Scientific Reports 2021. -
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
Authors:Reference: Neurology-Neuroimmunology & Neuroinflammation 2021. -
Characterization of multiple sclerosis lesions with distinct clinical correlates through quantitative diffusion MRI
Authors:Reference: Neuroimage-Clinical 2020. -
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Authors:Reference: Proceedings Of The National Academy Of Sciences Of The United States Of America 2019.
Featured Projects
-
Neuroimaging multi-modal approach to understand mechanisms of tissue DAmage in Multiple sclerosis patients and predictive models (daMoS)
Principal investigator: Sara Llufriu DuranFunder: Instituto de Salud Carlos IIICode: PI21/01189Duration: 01/01/2022 - 31/12/2024 -
Grup d'Imatge Avançada en Malalties Neuroimmunològiques (ImaginEM)
Principal investigator: Sara Llufriu DuranFunder: Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR)Code: 2021-SGR-01325Duration: 01/01/2022 - 31/12/2024 -
Rehabilitación cognitiva y plasticidad cerebral en la esclerosis múltiple: en búsqueda de la evidencia
Principal investigator: Albert Saiz Hinarejos, Sara Llufriu DuranFunder: Instituto de Salud Carlos III FIS-ISCIIICode: PI18/01030Duration: 01/01/2019 - 31/12/2021 -
Red española de esclerosis múltiple (REEM)
Principal investigator: Sara Llufriu DuranFunder: Ministerio de Ciencia e Innovación ; IDIBAPS (August Pi i Sunyer Biomedical Research Institute), Barcelona, Spain (Sede o evento)Code: RD16/0015/0003Duration: 01/01/2017 - 31/12/2021 -
Biomarcadores de resonancia magnética avanzada en esclerosis múltiple: asociación con el perfil clínico evolutivo y el sustrato genético
Principal investigator: Albert Saiz Hinarejos, Sara Llufriu DuranFunder: Instituto de Salud Carlos IIICode: PI15/00587Duration: 01/01/2016 - 30/11/2020